Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR® 2025-12-03 08:43
Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities 2025-12-02 22:00
Nature Communications | Insilico Medicine Presents AI-empowered Dual-Action PROTAC Targeting PKMYT1 2025-12-02 22:00
Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health 2025-12-02 22:00
Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health 2025-12-02 15:00
Amaran Biotech's Vaccine Adjuvant AB-801 Receives FDA Drug Master File (DMF) Filing Acknowledgement 2025-12-02 14:42
GC Biopharma's Varicella Vaccine Strain 'MAV/06' Listed in WHO Position Paper 2025-12-02 13:00
Lynk Pharmaceuticals Announces FDA IND Approval of Its Allosteric TYK2 Inhibitor LNK01006 2025-12-02 08:00
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI 2025-12-01 19:00
Lee's Pharm Supports Disaster Relief Efforts for Wang Fuk Court in Tai Po 2025-12-01 18:46
Hedia appoints new CEO: Rasmus Kofoed to succeed Lars Christian Lund 2025-12-01 16:00
The Wisdom Derived from the Great Migration: Hakka Medicine - The Unique "Medical Epic" of the Hakka People 2025-12-01 15:26
Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development 2025-11-30 18:15
BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough 2025-11-28 21:00
Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours 2025-11-28 13:00
The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma 2025-11-28 12:32
Strategic Partnership | Sanyou Bio and Korea's FatiAbGen Join Forces to Expand the Global Biopharma Market 2025-11-27 22:00
Once-Monthly GLP-1 RA | Gan & Lee Pharmaceuticals Initiates Phase 3 Clinical Study (GRADUAL-3) of the First Chinese Once-Monthly GLP-1 RA for Weight Management 2025-11-27 16:57
IASO Bio Announces BLA Approval of Fucaso (Equecabtagene Autoleucel) by the Hong Kong Department of Health for the Treatment of Relapsed or Refractory Multiple Myeloma 2025-11-27 13:44
SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation 2025-11-27 10:39
1 2 3 4 5 6 481